Vidipha Central Pharmaceutical JSC (HOSE:VDP)
53,000
0.00 (0.00%)
At close: Apr 28, 2026
HOSE:VDP Balance Sheet
Financials in millions VND. Fiscal year is January - December.
Millions VND. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2008 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Jan '25 Jan 1, 2025 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '08 Dec 31, 2008 |
Cash & Equivalents | 239,012 | 180,866 | 123,831 | 213,988 | 88,123 | 18,666 |
Short-Term Investments | 143,296 | 252,490 | 192,790 | 119,000 | 209,692 | 54,500 |
Cash & Short-Term Investments | 382,308 | 433,356 | 316,621 | 332,988 | 297,815 | 73,166 |
Cash Growth | 20.75% | 36.87% | -4.92% | 11.81% | 307.04% | 23.57% |
Accounts Receivable | 174,020 | 193,355 | 230,480 | 199,693 | 187,387 | 41,717 |
Other Receivables | 10,991 | 5,955 | 17,047 | 19,523 | 24,175 | 42.49 |
Receivables | 185,011 | 199,310 | 247,527 | 219,216 | 212,187 | 41,760 |
Inventory | 283,920 | 283,627 | 346,482 | 296,736 | 341,329 | 33,507 |
Prepaid Expenses | 11,840 | 1,591 | 2,416 | 2,019 | 373.94 | 1.42 |
Other Current Assets | 898.23 | 3,785 | 9,173 | 24,058 | 63,986 | 3,558 |
Total Current Assets | 863,977 | 921,669 | 922,220 | 875,016 | 915,692 | 151,992 |
Property, Plant & Equipment | 135,184 | 141,195 | 155,646 | 172,255 | 151,140 | 26,045 |
Long-Term Investments | - | - | - | 5,000 | 5,010 | 4,165 |
Other Intangible Assets | 44,150 | 44,372 | 39,179 | 38,926 | 27,822 | 9,236 |
Other Long-Term Assets | 537.78 | 8,786 | 8,401 | 1,245 | 204.32 | - |
Total Assets | 1,043,849 | 1,116,021 | 1,125,829 | 1,093,445 | 1,102,194 | 191,437 |
Accounts Payable | 62,129 | 104,417 | 53,269 | 36,594 | 71,407 | 13,074 |
Accrued Expenses | 15,455 | 37,120 | 50,788 | 40,518 | 53,455 | 1,356 |
Short-Term Debt | 171,097 | 198,387 | 258,438 | 273,139 | 336,307 | - |
Current Income Taxes Payable | 3,042 | 7,540 | 3,132 | - | 4,736 | 674.91 |
Other Current Liabilities | 30,136 | 18,485 | 8,432 | 11,211 | 9,696 | 6,658 |
Total Current Liabilities | 281,859 | 365,949 | 374,058 | 361,463 | 475,601 | 21,762 |
Other Long-Term Liabilities | - | - | - | - | - | 292.48 |
Total Liabilities | 281,859 | 365,949 | 374,058 | 361,463 | 475,601 | 22,055 |
Common Stock | 220,834 | 220,834 | 220,834 | 184,029 | 168,319 | 60,000 |
Additional Paid-In Capital | 179,852 | 179,852 | 179,852 | 216,657 | 176,040 | 61,803 |
Retained Earnings | 361,303 | 349,386 | 351,085 | 331,296 | 282,235 | 33,916 |
Comprehensive Income & Other | - | - | - | - | - | 13,664 |
Shareholders' Equity | 761,990 | 750,072 | 751,771 | 731,982 | 626,593 | 169,382 |
Total Liabilities & Equity | 1,043,849 | 1,116,021 | 1,125,829 | 1,093,445 | 1,102,194 | 191,437 |
Total Debt | 171,097 | 198,387 | 258,438 | 273,139 | 336,307 | - |
Net Cash (Debt) | 211,211 | 234,969 | 58,183 | 59,848 | -38,491 | 73,166 |
Net Cash Growth | 263.01% | 303.84% | -2.78% | - | - | 23.57% |
Net Cash Per Share | 9564.24 | 10640.06 | 2634.69 | 2963.04 | -1905.67 | 10160.92 |
Filing Date Shares Outstanding | 22.08 | 22.08 | 22.08 | 22.08 | 20.2 | 7.2 |
Total Common Shares Outstanding | 22.08 | 22.08 | 22.08 | 22.08 | 20.2 | 7.2 |
Working Capital | 582,118 | 555,719 | 548,162 | 513,553 | 440,091 | 130,230 |
Book Value Per Share | 34505.09 | 33965.43 | 34042.38 | 33146.14 | 31022.11 | 23525.33 |
Tangible Book Value | 717,840 | 705,700 | 712,592 | 693,056 | 598,772 | 160,147 |
Tangible Book Value Per Share | 32505.87 | 31956.16 | 32268.25 | 31383.47 | 29644.68 | 22242.61 |
Buildings | 166,402 | 166,402 | 155,975 | 149,233 | 124,746 | 23,592 |
Machinery | 263,100 | 262,557 | 258,001 | 251,362 | 217,337 | 42,578 |
Construction In Progress | 733 | 86.5 | 108.98 | 203.75 | 11,500 | 239.83 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.